ENZN
Price:
$0.08
Market Cap:
$5.94M
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.[Read more]
Industry
Biotechnology
IPO Date
1984-02-15
Stock Exchange
PNK
Ticker
ENZN
According to Enzon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -40695832.00. This represents a change of 8.45% compared to the average of -37526312.53 of the last 4 quarters.
The mean historical Enterprise Value of Enzon Pharmaceuticals, Inc. over the last ten years is -7312391.65. The current -40695832.00 Enterprise Value has changed 55.55% with respect to the historical average. Over the past ten years (40 quarters), ENZN's Enterprise Value was at its highest in in the September 2015 quarter at 22.60M. The Enterprise Value was at its lowest in in the March 2024 quarter at -40180676.25.
Average
-7312391.65
Median
4.06M
Minimum
-40066621.23
Maximum
18.49M
Discovering the peaks and valleys of Enzon Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 39.72%
Maximum Annual Enterprise Value = 18.49M
Minimum Annual Increase = -1067.94%
Minimum Annual Enterprise Value = -40066621.23
Year | Enterprise Value | Change |
---|---|---|
2023 | -40066621.23 | 39.72% |
2022 | -28676870.25 | 29.05% |
2021 | -22222362.50 | -37.31% |
2020 | -35448760.00 | -1067.94% |
2019 | 3.66M | -21.11% |
2018 | 4.64M | 4.08% |
2017 | 4.46M | -47.53% |
2016 | 8.50M | -54.04% |
2015 | 18.49M | 36.63% |
2014 | 13.53M | -69.43% |
The current Enterprise Value of Enzon Pharmaceuticals, Inc. (ENZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-30321951.33
5-year avg
-24550464.80
10-year avg
-7312391.65
Enzon Pharmaceuticals, Inc.’s Enterprise Value is less than PMV Pharmaceuticals, Inc. (47.77M), less than NewAmsterdam Pharma Company N.V. (1.37B), less than Tempest Therapeutics, Inc. (35.14M), less than IO Biotech, Inc. (-31528904.00), less than Molecular Pharmacology (USA), Ltd. (0), less than Curative Biotechnology, Inc. (10.02M), less than Kineta, Inc. (0), less than OncoVista Innovative Therapies, Inc. (6.78M), less than Neurobiological Technologies, Inc. (0), less than Polydex Pharmaceuticals Limited (0), less than Cyclacel Pharmaceuticals, Inc. (0), less than Living Cell Technologies Limited (7.95M), less than MultiCell Technologies, Inc. (-743753.00), less than Institute of Biomedical Research Corp. (7.92M), less than Health Sciences Group, Inc. (50.10K), less than Mymetics Corporation (25.90M), less than Eliem Therapeutics, Inc. (0), less than Molecular Partners AG (75.05M), less than Opthea Limited (119.64M), less than PureTech Health plc (132.68M), less than Acrivon Therapeutics, Inc. Common Stock (514.42M), less than null (376.11M), less than null (163.47M),
Company | Enterprise Value | Market cap |
---|---|---|
47.77M | $83.31M | |
1.37B | $1.87B | |
35.14M | $39.52M | |
-31528904.00 | $46.64M | |
0 | $11.15K | |
10.02M | $7.86M | |
0 | $7.05M | |
6.78M | $2.36K | |
0 | $2.70K | |
0 | $6.82M | |
0 | $2.24M | |
7.95M | $7.17M | |
-743753.00 | $50.01K | |
7.92M | $25.50M | |
50.10K | $187.09K | |
25.90M | $152.00 | |
0 | $342.68M | |
75.05M | $219.11M | |
119.64M | $486.27M | |
132.68M | $539.86M | |
514.42M | $202.87M | |
376.11M | $0 | |
163.47M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Enzon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Enzon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Enzon Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 3-year average Enterprise Value for Enzon Pharmaceuticals, Inc. (ENZN)?
What is the 5-year average Enterprise Value for Enzon Pharmaceuticals, Inc. (ENZN)?
How does the current Enterprise Value for Enzon Pharmaceuticals, Inc. (ENZN) compare to its historical average?